APA (7th ed.) Citation

Metzelder, S., Kröger, M., Reiter, A., & Dreger, P. (2012). High activity of sorafenib in FLT3-ITD-positive acute myeloid leukemia synergizes with allo-immune effects to induce sustained responses. Leukemia, 26(11), . https://doi.org/10.1038/leu.2012.105

Chicago Style (17th ed.) Citation

Metzelder, Stephan, Michael Kröger, Andreas Reiter, and Peter Dreger. "High Activity of Sorafenib in FLT3-ITD-positive Acute Myeloid Leukemia Synergizes with Allo-immune Effects to Induce Sustained Responses." Leukemia 26, no. 11 (2012). https://doi.org/10.1038/leu.2012.105.

MLA (9th ed.) Citation

Metzelder, Stephan, et al. "High Activity of Sorafenib in FLT3-ITD-positive Acute Myeloid Leukemia Synergizes with Allo-immune Effects to Induce Sustained Responses." Leukemia, vol. 26, no. 11, 2012, https://doi.org/10.1038/leu.2012.105.